M&A Deal Summary

Zimmer Biomet Acquires Cayenne Medical

On April 25, 2016, Zimmer Biomet acquired medical products company Cayenne Medical

Acquisition Highlights
  • This is Zimmer Biomet’s 12th transaction in the Medical Products sector.
  • This is Zimmer Biomet’s 11th transaction in the United States.
  • This is Zimmer Biomet’s 1st transaction in Arizona.

M&A Deal Summary

Date 2016-04-25
Target Cayenne Medical
Sector Medical Products
Buyer(s) Zimmer Biomet
Deal Type Add-on Acquisition
Advisor(s) Piper Sandler & Co. (Financial)
Snell & Wilmer (Legal)

Target

Cayenne Medical

Scottsdale, Arizona, United States
Cayenne Medical is a designer, developer and marketer of technically advanced soft tissue reconstruction solutions for the knee, shoulder and extremities. Cayenne Medical is based in Scottsdale, Arizona.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Zimmer Biomet

Warsaw, Indiana, United States

Category Company
Founded 1927
Sector Medical Products
Employees17,000
Revenue 7.7B USD (2024)
DESCRIPTION

Zimmer Biomet is a designer, developer, and manufacturer of orthopedic reconstructive, spinal, and trauma devices, dental implants, and related orthopedic surgical products. Zimmer Biomet was founded in 1927 and is based in Warsaw, Indiana.


DEAL STATS #
Overall 17 of 27
Sector: Medical Products M&A 12 of 19
Type: Add-on Acquisition M&A Deals 15 of 24
State: Arizona M&A 1 of 1
Country: United States M&A 11 of 19
Year: 2016 M&A 2 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-01 Ortho Transmission

Colorado, United States

Ortho Transmission LLC is a provider of transcutaneous osseous integrated skeletal implant technology services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-07 LDR Holding

Austin, Texas, United States

LDR Holding Corp. is a medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders.

Buy $1.0B